✦ LIBER ✦

Special problems associated with the bioanalysis of anti-cancer drugs

✍ Scribed by C. A. James; M. Breda; E. Frigerio; J. Long; K. Munesada

Book ID: 105594838
Publisher: Springer
Year: 2002
Tongue: English
Weight: 569 KB
Volume: 55
Category: Article
ISSN: 0009-5893
DOI: 10.1007/bf02493374

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Some problems associated with the quanti

Some problems associated with the quantitative analysis of crude hydroxy-anthraquinone drugs

✍ Seth Y.S. Ablordeppey; John S.K. Ayim 📂 Article 📅 1983 🏛 Elsevier Science 🌐 English ⚖ 409 KB

Ethical and practical problems of early

Ethical and practical problems of early anti-cancer drug trials: a review of the literature

✍ KAREN COX; Mark Avis 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 668 KB

Methodology problems associated with the

Methodology problems associated with the use of radioisotopically labelled drugs in drug metabolism studies

✍ R. E. Ober 📂 Article 📅 1966 🏛 John Wiley and Sons 🌐 French ⚖ 505 KB

What are the problems associated with th

What are the problems associated with the surgical treatment of patients with pancreatic cancer?

✍ Traverso, L. William 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 122 KB

Problems associated with the use of mert

Problems associated with the use of merthiolate as a preservative in anti-lymphocytic globulin

✍ Martin F. Heyworth; Sidney C. Truelove 📂 Article 📅 1979 🏛 Elsevier Science 🌐 English ⚖ 451 KB

1H NMR Characterization of Methacrylamid

1H NMR Characterization of Methacrylamide Polymer Conjugates with the Anti-Cancer Drug Doxorubicin

✍ V. Pinciroli; V. Rizzo; F. Angelucci; M. Tatò; A. Vigevani 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB 👁 1 views

Two poly-2-hydroxypropylmethacrylamide conjugates with the anti-cancer drug doxorubicin were investigated by 1H NMR spectroscopy. In both polymers (FCE 28068 and FCE 28069) the drug is connected to a polymethacrylamide backbone via a tetrapeptidyl spacer (Gly-L,D-Phe-L-Leu-Gly) and, in addition, FCE